findmyKOL
Clinical trialNCT06857942RecruitingPhase 4Interventional

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

SponsorEli Lilly and CompanyEnrollment200Overweight or ObesityPsoriasis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with moderate-to-severe plaque PsO and obesity or overweight with at least 1 weight-related comorbidity. The study will last up to 12 months.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Eli Lilly and Company

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

40 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Medical Dermatology Specialists

    Phoenix, Arizona, United States

    Lindsay Ackerman
    Recruiting
  • First Oc Dermatology Research Inc

    Fountain Valley, California, United States

    Vivian Laquer
    Recruiting
  • Center for Dermatology Clinical Research, Inc.

    Fremont, California, United States

    Sunil Dhawan
    Recruiting
  • Metropolis Dermatology

    Los Angeles, California, United States

    Yen (James) Wang
    Recruiting
  • Northridge Clinical Trials

    Northridge, California, United States

    Navid Ezra
    Recruiting
  • Neoclinical Research

    Hialeah, Florida, United States

    Martin Zaiac, MD
    Recruiting
  • Encore Medical Research

    Hollywood, Florida, United States

    Jerome Obed
    Recruiting
  • Skin Care Research

    Hollywood, Florida, United States

    Eduardo Weiss
    Recruiting
  • Moore Clinical Research, Inc. D/b/a Trueblue Clinical Research

    Tampa, Florida, United States

    Stephen Lockwood
    Recruiting
  • Truderm & Truspa

    Wellington, Florida, United States

    Andleeb Usmani
    Recruiting
  • Southeast Research Specialists

    Douglasville, Georgia, United States

    Firas George Hougeir
    Recruiting
  • Dawes Fretzin Clinical Research Group, Llc

    Indianapolis, Indiana, United States

    Scott Fretzin
    Recruiting
  • the Indiana Clinical Trials Center, Pc

    Plainfield, Indiana, United States

    Scott Guenthner
    Recruiting
  • Equity Medical - Bowling Green

    Bowling Green, Kentucky, United States

    James Allred
    Recruiting
  • Dermatology and Skin Cancer Specialists, Llc

    Rockville, Maryland, United States

    Benjamin Lockshin
    Recruiting
  • Metro Boston Clinical Partners

    Brighton, Massachusetts, United States

    Mark Amster
    Recruiting
  • David Fivenson, Md, Plc

    Ann Arbor, Michigan, United States

    David Fivenson
    Recruiting
  • Great Lakes Research Group, Inc.

    Bay City, Michigan, United States

    Brent Boyce
    Recruiting
  • the Derm Institute of West Michigan

    Caledonia, Michigan, United States

    Kristi Hawley
    Recruiting
  • Skin Cancer and Dermatology Institute - Reno

    Reno, Nevada, United States

    Michael Heaphy
    Recruiting
  • Stracskin

    Portsmouth, New Hampshire, United States

    Abel Jarell
    Recruiting
  • Psoriasis Treatment Center of Central New Jersey

    East Windsor, New Jersey, United States

    Alexa Hetzel
    Recruiting
  • Care Access - Hoboken

    Hoboken, New Jersey, United States

    Adolfo Fernandez- Obregon
    Recruiting
  • Equity Medical

    New York, New York, United States

    Michael Cameron
    Recruiting
  • Revival Research Institute, Llc

    Cary, North Carolina, United States

    Zain Husain
    Recruiting
  • Onsite Clinical Solutions - Huntersville

    Huntersville, North Carolina, United States

    Nicole Seminara-Zambrzycka
    Recruiting
  • Optima Research - Boardman

    Boardman, Ohio, United States

    Patrick Shannon
    Recruiting
  • Oregon Dermatology and Research Center

    Portland, Oregon, United States

    Phoebe Rich, MD
    Recruiting
  • Dermatology Associates of Plymouth Meeting

    Plymouth Meeting, Pennsylvania, United States

    Jonathan Wolfe
    Recruiting
  • Columbia Dermatology & Aesthetics

    Columbia, South Carolina, United States

    Jessica Burgy
    Recruiting
  • Delricht Research - Thompson'S Station

    Smyrna, Tennessee, United States

    Pezhman Shoureshi
    Recruiting
  • Bellaire Dermatology Associates

    Bellaire, Texas, United States

    Craig Teller
    Recruiting
  • Modern Research Associates, Pllc

    Dallas, Texas, United States

    Jennifer Cather
    Recruiting
  • Center for Clinical Studies

    Houston, Texas, United States

    Stephen Tyring
    Recruiting
  • Austin Institute for Clinical Research

    Pflugerville, Texas, United States

    Recruiting
  • Texas Dermatology and Laser Specialists

    San Antonio, Texas, United States

    John Browning
    Recruiting
  • Center for Clinical Studies

    Webster, Texas, United States

    PATRICIA LEE
    Recruiting
  • Tanner Clinic

    Layton, Utah, United States

    Scott Checketts
    Recruiting
  • Bellevue Dermatology Clinic

    Bellevue, Washington, United States

    Clive Liu
    Recruiting
  • Dermatology of Seattle

    Burien, Washington, United States

    Elie Levy
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
19 Mar 2025
Primary completion
31 May 2028
Completion
31 May 2028
Last update posted
3 Jun 2026
Registered enrollment
200
Registry id
NCT06857942

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.